Prenetics Global Management
Management criteria checks 2/4
Prenetics Global's CEO is Danny Yeung, appointed in Jan 2014, has a tenure of 12.25 years. directly owns 9.39% of the company’s shares, worth $28.47M. The average tenure of the management team and the board of directors is 3.3 years and 3.1 years respectively.
Key information
Danny Yeung
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.3yrs |
| CEO ownership | 9.4% |
| Management average tenure | 3.3yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 30% Share Price Bounce
Jan 30
Prenetics Global: Is Undervalued, Supported By Portfolio Optimization In 2026 (Buy)
Jan 17Market Participants Recognise Prenetics Global Limited's (NASDAQ:PRE) Revenues Pushing Shares 27% Higher
Sep 09Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 50% Share Price Bounce
May 11What You Can Learn From Prenetics Global Limited's (NASDAQ:PRE) P/S After Its 27% Share Price Crash
Mar 27Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 32% Share Price Bounce
Dec 16Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors
Oct 12Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump
May 29Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues
Apr 08Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%
Jan 07Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M
Sep 09CEO
Danny Yeung (46 yo)
Mr. Sheng Wu Yeung, also known as Danny, serves as Co-Founder, Chief Executive Officer and Director at Prenetics Global Limited since 2014 and serves as its Chairman. He served as Founding Partner at SXE V...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 12.3yrs | no data | 9.39% $ 28.5m | |
| Co-Founder & Chief Scientific Officer | 12.3yrs | no data | 3.19% $ 9.7m | |
| Chief Financial Officer | 8.3yrs | no data | 2.9% $ 8.8m | |
| Chief of Staff to Group CEO & Vice President of People & Operations | 3.3yrs | no data | no data | |
| Chief Clinical Officer | no data | no data | no data | |
| Chief Consumer Officer | 2.8yrs | no data | no data | |
| Director & President of Americas | 1.3yrs | no data | 0.24% $ 719.5k | |
| Chief Nutrition Officer | 1.3yrs | no data | no data |
Experienced Management: PRE's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 12.3yrs | no data | 9.39% $ 28.5m | |
| Director & President of Americas | 1.8yrs | no data | 0.24% $ 719.5k | |
| Chief Nutrition Officer | 1.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.1yrs | no data | no data | |
| Member of Scientific & Medical Advisory Board | no data | no data | no data | |
| Chairman of Scientific Advisory Board | 3.1yrs | no data | no data | |
| Independent Director | no data | no data | no data | |
| Member of Scientific & Medical Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 2.2yrs | no data | no data | |
| Member of Scientific & Medical Advisory Board | no data | no data | no data | |
| Member of Scientific & Medical Advisory Board | no data | no data | no data |
Experienced Board: PRE's board of directors are considered experienced (3.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/15 00:12 |
| End of Day Share Price | 2026/04/15 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Prenetics Global Limited is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ryan Meyers | Lake Street Capital Markets, LLC |
| George Kelly | Roth Capital Partners |
| Alexander Hantman | Sidoti & Company, LLC |